aprepitant
Showing 1 - 25 of 207
Obesity, Nausea and Vomiting, Postoperative Trial in Mexico City (Aprepitant, Placebo)
Active, not recruiting
- Obesity
- Nausea and Vomiting, Postoperative
- Aprepitant
- Placebo
-
Mexico City, MexicoHospital General Tlahuac
Mar 6, 2023
Hepatocellular Carcinoma Trial (Aprepitant in combination with granisetron and dexamethasone, Granisetron and dexamethasone)
Not yet recruiting
- Hepatocellular Carcinoma
- Aprepitant in combination with granisetron and dexamethasone
- Granisetron and dexamethasone
- (no location specified)
Feb 2, 2023
Breast Cancer Trial in Shanghai (Aprepitant, Mirtazapine)
Completed
- Breast Cancer
- Aprepitant
- Mirtazapine
-
Shanghai, ChinaFudan University Cancer Hospital
Apr 19, 2022
Determining Clinical Relevance of inTeraction Between AprepitaNt
Completed
- Testicular Cancer
- Blood sampling - Pharmacokinetic assessment
-
Nijmegen, NetherlandsRadboud UMC
Sep 9, 2022
Postoperative Nausea, Vomiting Trial in Ankara (Aprepitant, Granisetron)
Not yet recruiting
- Postoperative Nausea
- Vomiting
- Aprepitant
- Granisetron
-
Ankara, TurkeyBaskent University Ankara Hospital
Nov 18, 2022
Chemo-induced Nausea and Vomiting Trial in Toronto (Aprepitant Capsule 125 MG, Aprepitant oral suspension 20 mg/mL)
Completed
- Chemotherapy-induced Nausea and Vomiting
- Aprepitant Capsule 125 MG
- Aprepitant oral suspension 20 mg/mL
-
Toronto, Ontario, CanadaHospital for Sick Children
Apr 1, 2022
Postoperative Nausea and Vomiting, Bariatric Surgery Trial in Bern (Aprepitant 80 mg, Placebo)
Recruiting
- Postoperative Nausea and Vomiting
- Bariatric Surgery
- Aprepitant 80 mg
- Placebo
-
Bern, SwitzerlandDepartment of Anaesthesiology and Pain Medicine, Bern University
Mar 17, 2022
Heart Failure Trial in New Haven (LCZ 696, Placebo, Para-aminohippurate)
Recruiting
- Heart Failure
- LCZ 696
- +4 more
-
New Haven, ConnecticutYale New Haven Hospital
Dec 27, 2022
Pruritus Trial in Berlin (Aprepitant, Placebo)
Completed
- Pruritus
- Aprepitant
- Placebo
-
Berlin, GermanyAllergie-Zentrum-Charité, Charité - Universitätsmedizin Berlin
Jun 28, 2021
Gynecological Tumor Trial in Chengdu (Aprepitant Injection)
Not yet recruiting
- Gynecological Tumor
- Aprepitant Injection
-
Chengdu, Sichua, ChinaDengfeng Wang
Aug 22, 2023
Nausea With Vomiting Chemo-Induced Trial in Wuhan (Ondansetron every 3 weeks, Aprepitant, Dexamethasone)
Not yet recruiting
- Nausea With Vomiting Chemotherapy-Induced
- Ondansetron every 3 weeks
- +3 more
-
Wuhan, Hubei, ChinaHubei Cancer Hospital
Oct 8, 2023
Opioid Dependence Trial in New York (Aprepitant, Placebo pill)
Completed
- Opioid Dependence
- Aprepitant
- Placebo pill
-
New York, New YorkBellevue Hospital Center & the NYU School of Medicine
Aug 17, 2021
Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)
Not yet recruiting
- Breast Cancer
- Chemotherapy-induced Nausea and Vomiting
- Aprepitant
- +2 more
-
Hanzhou, Zhejiang, Chinathe Second Affiliated Hospital of Zhejiang Univercity School of
Apr 23, 2023
Chemo-induced Nausea and Vomiting, Colorectal Cancer Trial in Guangzhou (Aprepitant+Tropisetron, Dexamethasone+Tropisetron)
Completed
- Chemotherapy-induced Nausea and Vomiting
- Colorectal Cancer
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yat-sen University
Jul 24, 2021
Chemo-induced Nausea and Vomiting Trial in Moscow (Ondansetron, Dexamethasone, Aprepitant)
Recruiting
- Chemotherapy-induced Nausea and Vomiting
- Ondansetron
- +3 more
-
Moscow, Russian FederationZhukov Nikolay
Jul 27, 2022
NSCLC Trial in GuangZhou (Aprepitant, Desloratadine, Placebo of aprepitant)
Completed
- Non-small Cell Lung Cancer
- Aprepitant
- +3 more
-
GuangZhou, Guangdong, ChinaCancer Center of Sun-Yat Sen University (CCSYSU)
May 15, 2021
Nausea, Vomiting, Childhood Cancer Trial in Oklahoma City (Ondansetron, dexamethasone, aprepitant, Ondansetron, Dexamethasone, )
Completed
- Nausea
- +2 more
- Ondansetron, dexamethasone, aprepitant
- Ondansetron, Dexamethasone, placebo
-
Oklahoma City, OklahomaJimmy Everest Center for Cancer and Blood Disorders in Children
Mar 18, 2021
Myeloproliferative Disorder, Aquagenic Pruritus Trial in France (Aprepitant 80 mg, Hydroxyzine 25mg, Placebo of Hydroxyzine)
Recruiting
- Myeloproliferative Disorder
- Aquagenic Pruritus
- Aprepitant 80 mg
- +3 more
-
Brest, Brest Cedex, France
- +10 more
Jun 10, 2021
Chemo Induced Nausea and Vomiting, Pediatric Cancer Patients Trial in Shanghai (fosaprepitant, aprepitant, Granisetron plus
Not yet recruiting
- Chemotherapy Induced Nausea and Vomiting
- Pediatric Cancer Patients
- fosaprepitant
- +2 more
-
Shanghai, ChinaShanghai Children's Medical Center
May 5, 2021
Perioperative Optimization Trial in Pittsburgh (dietary supplement, drug, other)
Not yet recruiting
- Perioperative Optimization
- Neuraxial Analgesia
- +11 more
-
Pittsburgh, Pennsylvania
- +3 more
Jan 4, 2023
Breast Cancer Trial in Hong Kong (Experimental drug: Aprepitant, Experimental drug: Ondansetron, Experimental drug:
Completed
- Breast Cancer
- Experimental drug: Aprepitant
- +6 more
-
Hong Kong, Hong KongDepartment of Clinical Oncology, Prince of Wales Hospital
Jul 26, 2021
Type 2 Diabetes, Hypertension Trial in Nashville (Placebo, Sitagliptin, Aprepitant)
Completed
- Type 2 Diabetes Mellitus
- Hypertension
- Placebo
- +3 more
-
Nashville, TennesseeVanderbilt University
Feb 8, 2022
Soft Tissue Sarcoma Trial in Bordeaux, Montpellier, Toulouse (Patients starting a treatment with Doxorubicin and Ifosfamide)
Completed
- Soft Tissue Sarcoma
- Patients starting a treatment with Doxorubicin and Ifosfamide
-
Bordeaux, France
- +2 more
Jan 11, 2021
Post-operative Nausea and Vomiting, Laparoscopic Sleeve Gastrectomy Trial in Stony Brook (Aprepitant 80Mg Oral Capsule,
Completed
- Post-operative Nausea and Vomiting
- Laparoscopic Sleeve Gastrectomy
- Aprepitant 80Mg Oral Capsule
- +12 more
-
Stony Brook, New YorkStony Brook University Hospital
Mar 11, 2022